Abstract:Objectives To investigate the effect of simvastatin on anti-oxidation and anti-inflammation properties of high density lipoprotein (HDL) in apoE-/-mice fed with high-fat diet. Methods Eighteen 8-week old male C57BL/6J mice as blank control group were fed with normal diet, and thirty 8-week old male apoE-/-mice were fed with high-fat diet. Four weeks later, 6 mice in each group were sacrificed. The remaining 24 apoE-/-mice were randomly divided into two groups (12 each): atherosclerosis group (AS group) and simvastatin group, while the remaining 12 C57BL/6J mice served as control group. The mice in both control and AS group were fed with the original diet, and the mice in simvastatin group were fed with the same high-fat diet plus simvastatin 5mg/ (kg.d). At the end of the 8th and 16th week, 6 mice were sacrificed in each group. Serum lipid levels, paraoxonase 1 (PON1) activity (arylesterase activity), serum myeloperoxidase (MPO) activity, high-density lipoprotein inflammation index (HII) and serum hs-CRP levels were determined. The atherosclerotic lesion formation in the aorta was manifested by oil red O staining. Results At the end of the 8th week, no difference was found in the levels of serum low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) between simvastatin and AS group. At the end of 16th week, the levels of serum LDL-C decreased significantly (P<0.01) and HDL-C increased significantly (P<0.05) in simvastatin group compared with AS group. At the end of the 8th and 16th week, a significant enhancement of the serum PON1 activity but marked decrease in MPO activity, HII, and serum hs-CRP levels were found in simvastatin group compared with that in AS group. The percentage of plaque area (surface area of plaque/ surface area of whole intima in the aorta) was significantly smaller in simvastatin group than that in AS group (P<0.05 or P<0.01). Conclusions In addition to lowering LDL-C and elevating HDL-C, simvastatin could play a role of anti-atherosclerosis through reduction of aortic plaque formation by enhancing the anti-oxidation and anti-inflammation properties of HDL by increasing serum PON1 activity and decreasing MPO activity, serum hs-CRP levels, and HII.

The Combination of L-4F and Simvastatin Stimulate Cholesterol Efflux and Related Proteins Expressions to Reduce Atherosclerotic Lesions in Apoe Knockout Mice

Protective Effect and Mechanism of Apolipoprotein A-1 Mimetic Peptide L-4F on Atherosclerosis in Mice Model

Combined effects of atorvastatin and soybean isoflavones on hypercholesterolemia and lipoprotein metabolism

Apolipoprotein A-I Mimetic Peptide Inhibits Atherosclerosis by Altering Plasma Metabolites in Hypercholesterolemia.

Effect of simvastatin on cholesterol efflux and expression of ABCA1 and CD36 in THP-1 macrophages

Combined Effects of Cholesterol Reduction and Apolipoprotein A-I Expression on Atherosclerosis in LDL Receptor Deficient Mice

Effects and mechanism of simvastatin and fenofibrate on the expression of hepatic apolipoprotein M in mice

Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of P(53), Bcl-2 and Bcl-Xl

Endothelial Klf2-Foxp1-TGF signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling

Anti-Atherosclerotic Effects Mediated by the Combination of Probucol and Amygdalin in Apolipoprotein E-Knockout Mice Fed with A High Fat Diet

Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition

Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice

Effect of Simvastatin on Anti-Oxidation and Anti-Inflammation Properties of HDL in Apoe-/-mice

The Influence of Statin-Fibrate Combination Therapy on Lipids Profile and Apolipoprotein A5 in Patients with Acute Coronary Syndrome

Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation

Studies on the Simvastatin Effect on the Artery of Atherosclerotic Rabbit Using Proteomics Approaches

[Impact of Rosuvastatin on Atherosclerosis Lesions in Apolipoprotein E Knockout Mice].

L-4f, An Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation In Hypercholesterolemia And Sickle Cell Disease

Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A(2) in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits.

Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice.

Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.